Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
01/2001
01/04/2001CA2385798A1 Substituted phenoxyacetic acids
01/03/2001EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments
01/03/2001CN1278790A Chemical compound
01/02/2001US6169085 A viricide for preventing and treating retroviral infection or the spread of a retrovirus, inhibiting replication of a retrovirus and treating aids
12/2000
12/28/2000WO2000078724A2 Imidazolinderivatives their preparation and their pharmaceutical use
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/27/2000EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
12/27/2000CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1059898C Piperidine derivatives, prepn. method and use thereof
12/26/2000US6166227 Preparation of (S)-2-amino-6, 6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
12/26/2000US6166225 Processes for producing dialdehyde monoacetals
12/26/2000US6166074 Pharmaceutical compositions
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166008 Treatment of schizophrenia with ampakines and neuroleptics
12/26/2000US6166006 Having antagonistic activity on mcp-1 (monocyte chemoattractant protein-1) receptor; antiinflammatory agents
12/21/2000WO2000077027A2 Serine protease inhibitors
12/21/2000WO2000076991A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076970A2 Serine protease inhibitors
12/21/2000WO2000076961A1 Inhibitors of aspartyl protease
12/21/2000WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076489A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2383008A1 Compounds
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2374627A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
12/20/2000EP1060168A2 Method for preparing sulfanyl-type endothelin receptor antagonists
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/19/2000US6162926 Fullerenes derivatized with various compounds such as by cycloaddition, attaching to the carbon skeleton with 2 single bonds selected from carbon-carbon(c-c), c-oxygen, c-nitrogen and c-sulfur; pharmaceutical formulations
12/19/2000US6162810 Inadone and tetralone compounds for inhibiting cell proliferation
12/14/2000WO2000075128A1 Vinyl monomer, support matrix and its preparation
12/14/2000WO2000075104A1 Novel method for preparing optically active alpha-aminonitriles
12/13/2000EP1058550A1 Substituted semicarbazides and the use thereof
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/12/2000US6160134 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
12/12/2000US6160133 Stereospecific biosynthesis of the alcohol by enzymatic reduction of the corresponding aldehyde or ketone using a candida, zygosaccaromyces, or mortierrela microorganism
12/12/2000US6160130 Reacting alkylene oxide with carbon dioxide catalyzed by an alkali halide/manganese halide mixture
12/12/2000US6160068 Monomer and a polymer obtained therefrom
12/12/2000US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity
12/07/2000WO2000073289A1 Alpha-phenyl-beta-ketosulfone
12/07/2000WO2000073250A1 Treatment of a composition comprising a trimetlylohalkane bis-monolinear formal
12/06/2000EP1056739A1 Novel cyclic pro-perfumes having modifiable fragrance raw material alcohol release rate
12/06/2000EP1056734A2 Substituted alxoxycarbonyl compounds
12/06/2000EP1056700A1 Medicinal uses of phenylalkanols and derivates
12/05/2000US6156940 Reacting prochiral ketone with b-aminoalcohol in presence of metal borohydride and lewis acid or dialkylsulfuric acid; hydrogenation, reduction, hydroxylation
12/05/2000US6156937 Nonionic surfactants; water and oil repellency
12/05/2000US6156933 Continuous, selective catalysis; varying temperature, pressure, hydrogen concentration or flow rate
12/05/2000US6156909 Preparation of alkylene carbonate using indium halides and mixtures of same with lead halides as catalyst
12/05/2000US6156769 Antipruitus drugs for mammals
12/05/2000US6156160 Alkylene carbonate process
11/2000
11/30/2000WO2000071520A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000WO2000071500A1 Halogen compounds
11/30/2000DE19924668A1 Substituierte alpha-Phenyl-beta-Ketosulfone Substituted alpha-phenyl-beta-ketosulfones
11/30/2000DE19924159A1 Preparation of alkene from acetylene and amino, hydroxyl or carboxyl compounds in the presence of cesium fluoride and alkali hydroxide catalyst
11/30/2000CA2373789A1 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/29/2000EP1055658A2 Process for cis-1- 2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl pyrrolidine
11/29/2000EP1055654A1 Process for the preparation of organic compounds with imide catalysts
11/29/2000EP1054878A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/28/2000US6153769 Manufacture of polyene aldehydes
11/28/2000US6153759 Herbicide comprising a 5-membered or 6-membered heterocyclic, saturated or unsaturated radical containing one to three hetero atoms selected from the group consisting of oxygen, sulfur and nitrogen
11/28/2000US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders
11/28/2000US6153585 Arylsulfonanilide derivatives
11/23/2000WO2000069862A2 Hemisynthetic method and intermediates thereof
11/23/2000WO2000069839A1 Hydroxamic and carboxylic acid derivatives
11/23/2000WO2000069810A1 Glucagon antagonists/inverse agonists
11/23/2000WO2000034237A3 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
11/23/2000DE19922934A1 New 5,5-dihalo- or 4,5,5-trihalo-4-pentenoic acid derivatives, useful as bactericides, fungicides, insecticides, acaricides and nematocides, especially plant fungicides
11/23/2000CA2373892A1 Glucagon antagonists/inverse agonists
11/22/2000EP1053509A1 Photosensitive diazonaphthoquinone esters based on selected cyclic alkyl ether-containing phenolics and their use in radiation sensitive mixtures
11/22/2000CN1274355A Dcarboalkoxy dioxolanes as flavouring agent releasing compounds
11/21/2000US6150538 Peroxidation and acidification to form epoxides, hydrolysis to form erythroaleuritic acid or ester, heating with ortho ester to form dioxolane and pyrolysis to form hydroxyhexadecanoic acid then macrolactonization
11/21/2000US6150416 2-hydroxy-3-(substitued benzyl)-n,n'-bis(substituted carbonyl)-n-(substituted)-1,3-propanediamine based compounds; use in the detection, labelling and inhibition of cathepsin d
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067751A1 Aryl amidines, compositions containing such compounds and methods of use
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000CA2372496A1 Aryl amidines, compositions containing such compounds and methods of use
11/15/2000EP1052250A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/15/2000EP1051394A1 Potassium channel inhibitors
11/15/2000EP1051143A2 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
11/15/2000CN1273586A Method for preparation of asymmetric cyclic ureas through monoaylated diamine
11/14/2000US6147232 Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
11/14/2000US6147217 Synthesis of terfenadine and derivatives
11/14/2000US6147111 Kidney, brain, and cardiovascular disorders; vasodilation
11/14/2000CA2012432C N-(3-hydroxy-4piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran or dihydrobenzodioxin) carboxamide derivatives
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066556A1 Indoline derivatives as progesterone antagonists
11/09/2000WO2000066545A1 6-[[(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2371638A1 Indoline derivatives as progesterone antagonists
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 183